- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: relapsed multiple myeloma
Total 17201 results
-
Memorial Sloan Kettering Cancer CenterJanssen PharmaceuticalsActive, not recruiting
-
University of Maryland, BaltimoreActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Zhujiang HospitalThe Third Affiliated Hospital of Southern Medical University; Sun Yat-Sen Memorial... and other collaboratorsTerminatedRelapsed/Refractory Multiple Myeloma(MM)China
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, Australia, Poland, Ukraine, Germany, Spain, Turkey, Korea, Republic of, Brazil, Russian Federation, Netherlands, Hungary, Sweden, Czechia, Mexico
-
Janssen Research & Development, LLCCompletedMultiple MyelomaCanada, United States, Czechia, Israel, Italy, Korea, Republic of, Brazil, United Kingdom, Japan, Taiwan, Australia, Poland, Spain, France, Russian Federation, Sweden, Ukraine, Greece
-
City of Hope Medical CenterCompletedPlasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Secondary AmyloidosisUnited States
-
CARsgen Therapeutics Co., Ltd.Xiangya Hospital of Central South University; Peking University People's Hospital and other collaboratorsActive, not recruiting
-
GlaxoSmithKlineTerminatedRelapsed/Refractory Multiple MyelomaAustralia, Sweden, Canada
-
PfizerAvailableMultiple MyelomaUnited States, Canada
-
Mayo ClinicMultiple Myeloma Research FoundationCompletedRecurrent Plasma Cell Myeloma | t(11;14)United States
-
Avalo Therapeutics, Inc.CompletedMultiple MyelomaUnited States
-
AmgenActive, not recruitingRelapsed or Refractory Multiple Myeloma | Relapsed or Refractory Acute Myeloid LeukemiaUnited States, Australia, Japan, Germany, Canada
-
Shanghai Simnova Biotechnology Co.,Ltd.Active, not recruitingMultiple MyelomaChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Plasma Cell MyelomaUnited States
-
Stichting European Myeloma NetworkFondazione EMN Italy OnlusCompletedMultiple MyelomaGermany, Italy
-
CelgeneActive, not recruitingMultiple MyelomaUnited States
-
CelgeneActive, not recruitingMultiple MyelomaSpain, Canada, United States
-
Anaveon AGTerminatedHematologic Diseases | Multiple Myeloma | Refractory Multiple Myeloma | Adult Disease | Relapsed CancerSpain, Germany, France, Denmark, Switzerland
-
CelgeneCompletedMultiple MyelomaUnited States, Canada, Belgium, France, Germany, Italy, Japan, Spain
-
AmgenCompletedMultiple MyelomaUnited States, Australia
-
Weill Medical College of Cornell UniversityCelgeneActive, not recruiting
-
Emory UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; National Institutes...CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | ISS Stage III Plasma Cell Myeloma | ISS Stage II Plasma Cell Myeloma | ISS Stage I Plasma Cell MyelomaUnited States
-
Oncopeptides ABTerminatedMultiple MyelomaUnited States, Austria, Belgium, Czechia, Denmark, Estonia, France, Greece, Hungary, Israel, Italy, Korea, Republic of, Lithuania, Netherlands, Norway, Poland, Romania, Russian Federation, Spain, Taiwan, United Kingdom
-
CelgeneActive, not recruitingMultiple MyelomaFrance, United States, Canada, Spain, Italy
-
Juno Therapeutics, a Subsidiary of CelgeneActive, not recruitingMultiple MyelomaUnited States
-
Alfred Chung, MDMerck Sharp & Dohme LLCTerminatedMultiple Myeloma | Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma, RefractoryUnited States
-
University of LeedsCompletedRelapsed or Refractory Multiple MyelomaUnited Kingdom
-
Molecular Templates, Inc.TerminatedRelapsed and/or Refractory Multiple MyelomaUnited States
-
Icahn School of Medicine at Mount SinaiBristol-Myers Squibb; Multiple Myeloma Research ConsortiumEnrolling by invitation
-
NexImmune Inc.SuspendedRelapsed Refractory Multiple MyelomaUnited States
-
Wake Forest University Health SciencesBristol-Myers Squibb; Atrium Health Levine Cancer InstituteActive, not recruitingMultiple MyelomaUnited States
-
GlaxoSmithKlineActive, not recruitingMultiple MyelomaUnited States, Spain, France, Germany, Australia, United Kingdom, Canada, Italy
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Plasma Cell MyelomaUnited States
-
Fred Hutchinson Cancer CenterThe Leukemia and Lymphoma Society; Juno Therapeutics, Inc., a Bristol-Myers...TerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Alliance Foundation Trials, LLC.Pharmacyclics LLC.Active, not recruitingMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States
-
AmgenTerminatedRelapsed and/or Refractory Multiple MyelomaUnited States, Japan, Belgium, Australia, Switzerland
-
Janssen Research & Development, LLCNo longer availableRelapsed or Refractory Multiple MyelomaBelgium, Iceland, Portugal, Slovenia
-
TakedaTerminatedRelapsed and/or Refractory Multiple Myeloma (RRMM)United States, Canada
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
AmgenActive, not recruitingRelapsed Refractory Multiple MyelomaIndia
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Plasma Cell MyelomaUnited States
-
GlaxoSmithKlineActive, not recruitingMultiple MyelomaUnited States, Australia, Spain, Bulgaria, Poland, Belgium, France, Germany, Italy, Hungary, United Kingdom, Greece, Russian Federation, Brazil, China, Korea, Republic of, Japan, Canada, Netherlands
-
Ionis Pharmaceuticals, Inc.Active, not recruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
The First Affiliated Hospital of Soochow UniversityWithdrawnRelapsed/Refractory Multiple MyelomaChina
-
pharmaand GmbHCompletedMultiple MyelomaCanada, Spain, United States, Czechia, Turkey, France, Sweden, Korea, Republic of, Thailand, Belgium, Greece, Germany, Hungary, Russian Federation, Italy, Poland, Australia, Lebanon, Portugal, Norway, Brazil, Netherlands
-
CARsgen Therapeutics Co., Ltd.Active, not recruitingMultiple MyelomaUnited States, Canada
-
EMN Research ItalyActive, not recruitingRelapsed Multiple MyelomaItaly
-
PfizerCompleted
-
Washington University School of MedicineBristol-Myers Squibb; CelgeneActive, not recruitingMultiple Myeloma in RelapseUnited States, Canada